In May 2023, the company received European Commission approval for CAR-T Therapy, Breyanzi for Relapsed or Refractory Large B-cell Lymphoma after one prior therapy. In June 2023, BMS’s third commercial scale CAR T manufacturing facility in Devens (US) received FDA approval. In the previous ...
its CD19 CAR T therapy. Helping propel that momentum is Biontech SE, another CAR T therapy developer. For $50 million cash, Biontech bought the rights to use Autolus’ manufacturing and commercial infrastructure in the U.K. so it can advance its CAR T-cell BNT-211 program in the clinic....
自从首款嵌合抗原受体T 细胞(chimeric antigen receptor T cell,CAR-T cell)治疗产品被美国食品药品监督管理局(Food and Drug Administration,FDA) 批准上市以来,CAR-T在血液肿瘤领域的临床治疗中取得了可观的成果, 全球的CAR-T 细胞...
恒瑞源正;李建强 博士, 河北森朗生物;李华顺 博士 , 苏州阿思科力生物( CAR-NK );Dr. John Connolly, 新加坡特沙生物 [ Virus Specific T cell (VST) Platform ];李烈涛 博士, 新加坡来恩生物 ( TCR-T
which together have resulted in high cell transduction, high gene editing rates and high cell survival, as well as providing high yields and quality cell therapy products. Allogenic CAR T-cell products are appealing as they have potential to be immediately ...
which is reflected in a strong pipeline of multiple CAR-T and TCR constructs. We also see tremendous opportunity for leading cell and gene therapy companies based outside of China to partner with CBMG, leveraging the Company’s manufacturing expertise and the favorable regulatory environment in Chin...
Under the multi-year agreement, the companies will research and develop two new CAR-T cell therapies specified by AbbVie. Caribou will be responsible for pre-clinical research, development, and manufacturing activities, while AbbVie will be responsible for all clinical development, ...
"Cell therapies like CAR T cells offer important new treatment options for cancer patients, and WuXi aims to be at the forefront of this area of providing our partners with cutting-edge cGMP manufacturing capabilities and capacities," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. ...
CAR T-Cell Therapy Market Analysis The Global CAR T-Cell Therapy Market size is estimated at USD 5.77 billion in 2025, and is expected to reach USD 13.36 billion by 2030, at a CAGR of 18.27% during the forecast period (2025-2030). The COVID-19 pandemic has significantly impacted the CA...
Volkswagen (VWAGY) is a Germany-based multinational automotive manufacturing company. It develops and produces passenger cars, trucks, and light commercial vehicles such as buses. Vehicle models include the Tiguan, Golf, Jetta, Passat, and more. The company stopped making its once-popular Volkswagen...